|
|||||
|
|
19 Erlotinib in the treatment of non-small-cell lung cancer |
|
| Affiliation: | 1. Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences;2. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Center Isfahan University of Medical Sciences;3. Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IRAN |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |